Allied Market Research published a report, titled, “Anticoccidial Drugs Market by Drug Class (Ionophore, Synthetic Drugs), by Drug Action (Coccidiostatic, Coccidiocidal), by Animal Type (Poultry, Cattle, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global anticoccidial drugs industry was estimated at $171.3 million in 2021, and is anticipated to hit $257.8 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chains, competitive scenarios, and regional landscapes.
Determinants of growth-
Rise in the development of advanced anticoccidial drugs and surge in government initiatives for infusing awareness about coccidiosis and its medications drive the growth of the global anticoccidial drugs market. On the other hand, stringent government guidelines that restrict the usage of anticoccidial drugs in livestock and the use of alternative medicines such as vaccines and herbal medicines to treat coccidiosis impede the growth to some extent. However, availability of new products at affordable rates is anticipated to create lucrative opportunities in the industry.
Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/15213
Covid-19 scenario-
- The transport or travel restrictions and several social distancing measures made it difficult for animal owners to collect the medications and treatments they need from veterinary practices. The government and other authorities imposed strict measures for containing the Covid-19 pandemic. These factors impacted the global anticoccidial drugs market.
- However, the market has now recovered slowly and got back on track.
The synthetic drugs segment to rule the roost-
By drug class, the synthetic drugs segment contributed to nearly three-fifths of the global anticoccidial drugs market revenue in 2021, and is projected to dominate by 2031. Increasing use of synthetic drugs in the control & prevention of diseases and surge in the prevalence of coccidiosis diseases fuel the segment growth. The lonophore segment, simultaneosuly, would showcase the fastest CAGR of 4.5% from 2022 to 2031.
The coccidiostatic segment to maintain the highest share-
By drug action, the coccidiostatic segment garnered the highest market share in 2021, accounting for more than three-fifths of the global anticoccidial drugs market revenue. The same segment would also cite the fastest CAGR of 4.5% from 2022 to 2031. This is due to surge in adoption of drugs with coccidiostatic mode of action and rise in research & development activities for the development of coccidiostatic medicines.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/15213
The others segment dominated the market-
By animal type, the others segment garnered more than two-fifths of the global anticoccidial drugs market revenue in 2021, and is expected to rule the roost by 2031, due to rise in demand for pet animals. The cattle segment, however, would showcase the fastest CAGR of 4.6% during the forecast period.
North America grabbed the lion’s share-
By region, the anticoccidial drugs market across North America held the major share in 2021, contributing to more than two-fifths of the global market revenue, owing to high prevalence of coccidiosis, increase in the number market players and surge in the population of meat producers across the region. The Asia-Pacific region, on the other hand, would cite the fastest CAGR of 5.6% during the forecast period. The presence of high populace countries such as India and China heightens the prevalence rate of coccidiosis diseases, which propels the market growth. Also, increasing number of strategies and trends adopted by the market players has supplemented the market growth.
Key players in the industry-
- Boehringer Ingelheim International GmbH
- Ceva sante animale
- Dosh Pharmaceuticals Private Limited
- Huvepharma EOOD
- Merck & Co., Inc.
- Zoetis Inc.
- Bayer AG
- Venkateshwara hatcheries Private Limited
- Vetoquinol SA
- Virbac SA
The report analyzes these key players in the global anticoccidial drugs market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
